Cedars-Sinai Medical Center
Los Angeles, California, United States
Katie Grausam, PhD, earned her Bachelors of Science degrees in Human Biology and Psychology at Michigan State University, followed by Masters of Science degrees in Neuroscience and Science Education at Florida State University. In 2018, she completed her doctorate in Basic Biomedical Sciences at the University of South Dakota/Sanford School of Medicine, with a focus on the involvement of transcription factor ATOH1 in metastatic medulloblastoma, the most common pediatric brain tumor. Currently, as a postdoctoral scientist in the Breunig Lab at Cedars-Sinai Medical Center, she is generating new preclinical models of glioblastoma that recapitulate the patient tumor mutation profile, and investigating the involvement of the immune microenvironment, a project in collaboration with Dr. Stephen Shiao.
